Publications by authors named "Melisa Cooper"

Claim this Profile
V
Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.
Melisa Cooper, David Z I Cherney, Tom H Greene, Hiddo J L Heerspink, Meg Jardine

J Am Soc Nephrol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.
Melisa Cooper, Robin O'Connor-Semmes, Beth Ann Reedy, Kimberley Hacquoil, Peter Gorycki

Clin Pharmacol Drug Dev· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience of Symptoms and Disease Impact in Patients with Adenomyosis.
Linda M Nelsen, William R Lenderking, Robin Pokrzywinski, Zaneta Balantac, Libby Black, Melisa Cooper

Patient· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and Multiple-Day Dosing Studies to Investigate High-Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers.
Kelly M Mahar, Mary Beth Enslin, Angie Gress, Heather Amrine-Madsen, Melisa Cooper

Clin Pharmacol Drug Dev· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee.
Nancy J Olsen, Valerie K Branch, Geetha Jonnala, Mira Seskar, Melisa Cooper

BMC Musculoskelet Disord· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis